trending Market Intelligence /marketintelligence/en/news-insights/trending/9T2YCZwNVAnR1QJMyn1w5g2 content esgSubNav
In This List

Acceleron raises additional funds in common stock offering

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Acceleron raises additional funds in common stock offering

Acceleron Pharma Inc. said the underwriters for its previously announced offering fully exercised their overallotment option to buy an additional 810,810 common shares at $37 apiece.

The total net proceeds from the offering now stand at $215.8 million.

J.P. Morgan Securities LLC, Citigroup and Leerink Partners LLC acted as the joint book-running managers for the offering.